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Abstract
Nuclear magnetic resonance (NMR) spectroscopy is integral to metabolic stud-
ies; yet, it can suffer from the long acquisition times required to collect data of
sufficient signal strength and resolution. The use of non-uniform sampling
(NUS) allows faster collection of NMR spectra without loss of spectral integrity.
When planning experimental methodologies to perform metabolic flux analysis
(MFA) of cell metabolism, a variety of options are available for the acquisition
of NUS NMR data. Before beginning data collection, decisions have to be made
regarding selection of pulse sequence, number of transients and NUS specific
parameters such as the sampling level and sampling schedule. Poor choices
will impact data quality, which may have a negative effect on the subsequent
analysis and biological interpretation. Herein, we describe factors that should
be considered when setting up non-uniformly sampled 2D-1H,13C HSQC NMR
experiments for MFA and provide a standard protocol for users to follow.
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1 | INTRODUCTION
Stable isotope tracing is routinely used to elucidate the
activities of various metabolic pathways inside biological
systems, from whole organisms to individual cells.[1–7]
Metabolic substrates enriched with stable isotopes, such
as 13C labelled glucose and glutamine, are used to trace
the metabolism of a system. Metabolic transformations
distribute labelled atoms into downstream metabolites
that can be detected using techniques such as mass spec-
trometry (MS) and nuclear magnetic resonance (NMR)
spectroscopy. Combining data on overall incorporation of
isotopes available from MS and NMR spectroscopy allows
detailed examination of the fate of atoms throughout a
metabolic system.[7]
NMR spectroscopy is uniquely able to give informa-
tion on the position of isotopically labelled nuclei, in con-
trast to the more sensitive technique of MS, which can
only provide the relative amounts of each isotope isomer
(isotopomer). In 1H decoupled 1D-13C NMR spectra, the
multiplet pattern of an NMR peak is a result of the con-
stituent isotopomers (see Figure 1B). In order to use this
information to calculate the corresponding contributions
from each isotope position, additional information is
needed. As 1D-13C NMR spectroscopy is blind to 12C, the
multiplet information must be scaled to derive the rela-
tive contribution of unlabelled nuclei (i.e., molecules
containing 13C nuclei only at natural abundance).
Such scaling can be provided either by determining
the per carbon 13C percentage[10–15] or by employing the
Received: 3 April 2020 Revised: 6 August 2020 Accepted: 18 August 2020
DOI: 10.1002/mrc.5089
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
© 2020 The Authors. Magnetic Resonance in Chemistry published by John Wiley & Sons Ltd
Magn Reson Chem. 2020;1–13. wileyonlinelibrary.com/journal/mrc 1
isotopomer distribution derived from MS data.[7] Once
this scaling has been completed, the data from the multi-
plet patterns of the 13C NMR spectra can be used to deter-
mine position specific 13C distribution in each molecule.
The detected 13C multiplet pattern can be interpreted
directly, known as tracer analysis, or it can be integrated
into a more demanding metabolic flux analysis (MFA)
that requires metabolic network models to extract in vivo
reaction rates.[3] For the remainder of this article, we will
use the term MFA to include tracer analysis. MFA pro-
vides valuable biological insights, highlighting the rela-
tive activity of different metabolic pathways and the
nutrient contribution to metabolites from labelled
substrates.
The structure and labelling pattern of metabolites can
be determined using a variety of NMR experiments. Posi-
tional enrichment of isotopes provides information on the
active metabolic pathways, and this detailed isotopomer
analysis can use a mixture of experiments. 1D-1H spectra
provide a wealth of information; however, the narrow fre-
quency range results in significant resonance overlap that
complicates peak integration. Isotopically enrichedmetab-
olites can be identified directly from the 13C satellites in
proton spectra,[14] or 1D-13C NMR spectra can be used to
elucidate positional isotopomers. However, the low sensi-
tivity of 13C nuclei and their longer relaxation times limits
this approach to concentrated samples, even when 13C-
optimised probes are employed.[15]
Whereas 1D-1H NMR experiments are often faster
compared with 2D NMR experiments, the same is not nec-
essarily true for 1D-13C NMR experiments. Two-
dimensional 1H,13C correlation NMR experiments are
usually 1H detected and are therefore more sensitive due
to the different gyromagnetic ratios of 1H and 13C. In addi-
tion, 2D-1H,13C correlation NMR experiments reduce con-
gestion of signals and aid identification by dispersion of
FIGURE 1 Schematic 2D-1H,13C HSQC spectrum of glutamate with multiplet analysis of the C(2) signal. Panel A shows the 2D-HSQC
spectrum with the signals for C(2), due to chemical shift differences of the two protons attached to C(3) two signals for C(3) and the signal
for C(4) all indicated. Panel B shows the experimental (amber) and simulated (green) multiplet obtained from the 13C dimension of the C
(2) signal with percentages of each potential isotopomer derived from fitting the intensity of the four possible multiplet components
displayed in panels C–F to an experimental spectrum. The schematic representations of glutamate displayed next to each 1D spectrum show
white circles for unlabelled carbon atoms, black circles for labelled carbon atoms and grey circles where carbon atoms can either be 12C or
13C without affecting signal multiplicity. C(2) of glutamate is always shown in green. The signal fitting was performed within the MetaboLab
software,[8] using the pyGamma library[9] for NMR lineshape simulations. The 1D-13C slice of the 2D-NMR spectrum was simulated as a
1D-13C spin echo NMR spectrum with the echo time set to 1.55 ms to account for the gradient selection 13C spin-echo within the 2D-1H,13C
HSQC NMR pulse sequence
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chemical shift into the two dimensions. The toolbox of
NMR methods for isotopomer analysis includes acquisi-
tion techniques such as 2D-HSQC and HMBCNMR exper-
iments, which correlate proton frequencies with the
relevant heteronucleus (usually 13C or 15N in MFA
experiments),[16] and the HSQC-TOCSY NMR experi-
ment, which can be used to identify molecules with multi-
ple labels.[17] Another possible approach used to speed up
data acquisition is to reduce the relaxation delay between
transients, and such fast 2D approaches have demon-
strated that 2D-1H,13C correlation NMR spectra can be
obtained using experiment times of less than half an
hour.[18,19] Complete 2D correlations can be acquired in a
single scan, and ultrafast zTOCSY and COSY techniques
have been used to measure specific 13C enrichments.[20]
Positional 13C percentages can be derived from a vari-
ety of different NMR spectra such as various forms of
1D-1H NMR spectra[10–12,14,15] or 2D-1H,1H TOCSY NMR
spectra.[13] Spectral congestion can be a real problem for
1D-1H NMR spectra. Although this can be resolved
through the use of 2D-1H,1H TOCSY NMR spectra, there
can still be substantial overlap, which can make it impos-
sible to obtain fully quantitative data for some carbon
atoms in key metabolites (e.g., C(2) of glutamate, gluta-
mine and the glutamyl part in glutathione). The use of
MS-derived mass isotopomer distributions in a full iso-
topomer analysis can overcome these problems.[7] In
addition, the use of two orthogonal analytical technolo-
gies such as NMR spectroscopy and MS serves as an inte-
grated consistency check. The use of a 2D-1H,13C HSQC
NMR pulse sequence in combination with gas chroma-
tography coupled MS (GC-MS)-based mass isotopomer
distribution data is one of the most effective ways to trace
the incorporation of 13C nuclei into metabolites.[7] Using
typical settings, the cross-peaks appearing in a 2D-1H,13C
HSQC NMR spectrum are 1H nuclei bonded directly to
13C nuclei and yield well-resolved spectra. Figure 1 dem-
onstrates the information content of a high-resolution
2D-1H,13C HSQC NMR spectrum. Whereas panel A
depicts an overview plot of the 2D-1H,13C HSQC NMR
spectrum of glutamate, panel B shows a high resolution
slice through the 13C multiplet (in amber) and a simula-
tion of the multiplet line shape (green) of the indirect
(13C) dimension for the signal of C(2) of glutamate. The
percentages indicate how much each component contrib-
utes to the overall multiplet. Panels C–F plot each multi-
plet component. A schematic representation of glutamate
was added to each subpanels B–F with black circles indi-
cating 13C labelled nuclei, white circles representing 12C
nuclei. Because the signal of C(2) is shown here, C(2) is
always 13C and is shown in green. Circles shown in grey
can be either 12C or 13C nuclei without affecting the mul-
tiplet of C(2) of glutamate.
As the length of the free induction decay (FID) in the
13C dimension dictates the resolution of the 13C dimen-
sion of the 2D NMR spectrum, it is necessary to acquire
large numbers of increments resulting in a long experi-
ment time. This is impractical when dealing with multi-
ple samples; however, reductions in experimental times
can be made with non-uniform sampling (NUS).[21] NUS
schedules are designed to collect only a fraction of the
data points after which reconstruction algorithms convert
the NUS data into a full signal. NUS is therefore a vital
technique in facilitating the acquisition of NMR data for
metabolic tracing in a reasonable time frame. Further
time savings can be achieved through enhancing the sig-
nal splitting due to J-coupling in the 13C dimension, all-
owing a reduced number of increments to be acquired
while still being able to resolve the individual compo-
nents of the multiplets. Enhanced splitting also enables
the use of higher field spectrometers, providing greater
signal-to-noise ratio without the need to collect extra
increments that would otherwise be required to resolve
the splitting due to J-coupling.[15,22] NUS approaches
have also been used to obtain high resolution NMR spec-
tra without resolving 13C–13C coupling patterns to
increase chemical shift accuracy and other coupling pat-
terns in two-dimensional NMR spectra.[23,24]
There are a number of options to be considered
when designing the experimental approach, from the
choice of tracer to the selection of pulse sequences, sam-
pling level or sampling schedule. Some of these options
will have significant effects on data quality and preci-
sion. While we will not discuss options dictated by the
biological problem, such as choice of tracer, we will
explore NMR data acquisition-related options. Specifi-
cally, we will test the consequences of the choice of
pulse sequence, number of transients acquired, sampling
level and sampling schedule then explore the potential
of using 2D-HSQC NMR spectra suitable for MFA stud-
ies in high-throughput settings (i.e., acquisition of
2D-1H,13C HSQC NMR spectra well enough resolved to
analyse 13C–13C J-coupling patterns in under 15 min).
We will use the results to recommend a standardised
approach for the acquisition of non-uniformly sampled
2D-HSQC NMR data for MFA.
2 | PULSE SEQUENCES
Modern NMR spectrometers offer a variety of different
pulse sequences for the acquisition of 2D-HSQC NMR
spectra, each of which with its own advantages and dis-
advantages. We tested three different pulse sequences
with respect to signal-to-noise ratio and artefact levels.
The pulse sequences tested were a States-TPPI-based
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sequence[25] and two echo/anti-echo (E/A)-based
sequences,[26–28] one of which included sensitivity
enhancement, and the other pulse sequence did not. Ini-
tially, 2D-1H,13C HSQC NMR spectra were acquired with
full sampling, to separate the influence of pulse sequence
on the measured parameters from artefacts generated by
the use of NUS. In order to limit experimental time, two
transients were used for 8,192 complex increments.
While the spectra acquired using an E/A-based pulse
sequence are virtually artefact free (Figure 2A), the use of
States-TPPI for quadrature detection results in significant
artefacts especially in the crowded regions of the spec-
trum (Figure 2B). In addition to artefacts that look
similar to t1 noise, artefactual signals can be observed in
the middle and at the edges of the spectrum due to insuf-
ficient phase cycling. As a consequence, it is impossible
to faithfully detect signals from nuclei such as the C(2) of
alanine, even though the presence of splitting in the C
(3) of alanine shows that it must be labelled and therefore
should be observable in the NMR spectrum. Another
consequence of the insufficient artefact suppression using
a States-TPPI-based pulse sequence with only two tran-
sients is that it is impossible to phase all the NMR signals
in the spectrum simultaneously. For example, the methyl
group signals of alanine and lactate are about 7.2 out of
phase in the 13C dimension even though they are in
FIGURE 2 Fully sampled 2D-1H,13C HSQC NMR spectra of a sample of cell extract collected using either E/A (A) or States-TPPI
(B) for quadrature detection. The spectra were acquired without enhancement of the 13C–13C splittings. Peaks from the detectable carbons of
alanine are indicated along with regions selected for noise calculation. Artefacts that are not edited out in the phase cycle are highlighted.
The 13C traces for the C (2) and C (3) carbons of alanine are shown for spectra collected using E/A both with and without sensitivity
improvement together with the traces of regions without peaks to allow estimation of noise levels (C). The overlay of 13C traces for the C
(2) and C (3) carbons of alanine collected with States-TPPI and E/A are shown together with the noise region (D). Overlaid spectra are
shown with the same peak intensity relative to each other
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spectral proximity. Because the analysis of 2D-HSQC
NMR spectra in MFA studies critically depends on proper
phasing of the spectrum, this will prevent a quantitative
analysis of such spectra. The use of E/A quadrature
detection results in much improved artefact suppression
even when using just two transients. The slightly twisted
line shape, due to the homonuclear 13C–13C J-coupling
contribution to the first increment in the 13C dimension,
must not be confused with the differences in phase
observed for several signals in the States-TPPI spectrum.
E/A HSQC spectra can be easily phased, and as the signal
distortion is predictable, it can be accounted for in a
quantitative analysis such as a line shape simulation.
This makes E/A-based pulse sequences ideal for collec-
tion of 2D-1H,13C HSQCs NMR spectra with high resolu-
tion in the 13C dimension.
The signal from areas of the spectrum where no reso-
nances are expected can be used as a measure of both the
noise and the artefact levels present. It can clearly be
seen that the use of E/A for quadrature detection results
in significantly smaller signals in the empty regions of
the spectrum confirming the smaller numbers of artefacts
compared with the States-TPPI (Figure 2).
Sensitivity enhancement used in conjunction with
E/A results in the expected modifications in peak inten-
sity with an increase in peak intensity for CH groups but
no enhancement for CH3 (Figure 2C). However, there is
an increase in the J-coupling contribution in the first
increment, which results in a change in line shape. In
protein NMR spectroscopy, the observed groups often
have a common quality, for instance the amide group of
the peptide bond, where the number of protons attached
to nitrogen is one. In contrast, small molecules
(e.g., metabolites) have a range of different groups, and
the numbers of protons attached to the heavy atoms vary,
so to cover the widest range of observable signals, the use
of sensitivity enhancement is not recommended.
In summary, E/A is the most suitable variant of
2D-HSQC NMR pulse sequences for measuring
2D-HSQC NMR spectra with high resolution in the 13C
dimension due to the quality of data acquired with a
phase cycle that requires only two transients.. The lack
of artefacts present in the spectra acquired using E/A
lends itself to being used in conjunction with NUS as
artefacts present in the normally acquired spectra will
be amplified by the use of NUS. A quantitative analysis
of such spectra necessitates the use of line shape simu-
lations to account for the presence of 13C–13C J-coupling
contributions to the first increment in the 13C dimen-
sion. The use of States-TPPI inevitably leads to
increased artefact levels, which may bias data analysis
of such spectra. In addition, we observed that some
areas of the State-TPPI spectrum are unusable due to
the insufficient filtering of residues from large peaks
(C(2) of alanine, for example).
3 | INFLUENCE OF NUMBER OF
TRANSIENTS ON SIGNAL-TO-
NOISE RATIO
When collecting NMR data, there is always a balance
between the time taken to acquire the spectra and the
signal-to-noise ratio that can be achieved. Metabolic trac-
ing samples are often mass limited; therefore, various
measures must be taken to optimise signal-to-noise. Pro-
bes designed to handle very low volumes are used to
make best use of the sample available together with the
greater sensitivity of the highest field magnets available.
The 1.7-mm TCI CryoProbe working at 800 MHz is
the best set-up currently available. While increasing the
number of transients will lead to stronger signals, the
time taken may be prohibitively long and result in a
reduction of the number of samples that can be run in
any given period. The E/A 2D-HSQC NMR pulse
sequence can be used with a minimum of two transients.
However, does this result in enough signal, or could
increasing the number of transients give better data and
also result in a decrease in artefacts? As demonstrated in
Figure 3, there is no appreciable increase in artefacts
when using two transients as opposed to four or eight
(Figure 3A,C). All the fine features of the peak multiplets
are present, and there is only a small increase in the
signal-to-noise seen when increasing from two transients
to eight. The benefit from collecting more transients
when using NUS does not result in the same increase in
signal-to-noise as with fully sampled spectra, and a better
use of time may be to increase the sampling level. The
case with the States-TPPI 2D-HSQC NMR pulse sequence
is different. While isolated signals, such as the methyl
group of alanine (Figure 3D), follow the same pattern as
signals in the E/A 2D-HSQC NMR spectrum (Figure 3A,
C), signals in areas of the spectrum with signals from
highly labelled molecules such as glucose, which possess
signals with a distinctive 13C but very similar 1H chemi-
cal shifts, may not be observable due to spectral artefacts
overshadowing these signals. An example is demon-
strated in Figure 3B, where the equivalent trace of the
two transient E/A 2D-HSQC NMR spectrum was plotted
as well.
It is important to note that the main issue arising
from the choice of pulse sequences is not the signal-to-
noise but rather the signal-to-artefact ratio. The presence
of artefacts (which can appear as noise) severely limits
the use of the data that can compromise the resultant
analysis. In summary, it confirms that even if the full
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phase cycle is used, the States-TPPI 2D-HSQC NMR pulse
sequence is not suitable for MFA studies and that the
E/A-based 2D-HSQC NMR pulse sequences are the most
suitable for this purpose because of the efficient filtering
of artefacts from the collected spectra and can be used
with only two transients per increment.
It should be noted that all non-uniformly sampled
spectra presented in this study were reconstructed using
the IRLS[29,30] algorithm with 20 iterations using the
NMRPipe[31] and qMDD[30,32] software packages. There
was no difference found in spectra reconstructed using
iterative soft thresholding (IST)[33,34] with 400 iterations
and those using IRLS so either approach is applicable to
MFA studies.
4 | MINIMUM SAMPLING LEVEL
REQUIRED
As we routinely collect 8,192 complex increments in the
fully sampled spectra, even a relatively low sampling level
will result in a relatively large number of points being col-
lected. As discussed above, the sampling level may be
kept high to maximise signal-to-noise but if the amount
of sample is high enough such that signal is not an issue
then what is the minimum sampling level required?
There is no noticeable increase in artefacts when reduc-
ing the sampling from 50% to 20% and the ratio of signal-
to-the-noise region of the spectrum remains stable
(Figure 4). However, when the sampling level is dropped
to below 20%, some fine features of the multiplet are lost,
and so, the use of very low sampling levels is not rec-
ommended for general use if the dynamic range of
observable signals is not to be limited. The isotope distri-
butions calculated from data with various sampling levels
(Table 1) are similar. However, the minor contributions
of the 13C(1),13C(2),12C(3) and 12C(1),13C(2),13C(3) compo-
nents of the C(2) lactate multiplet are lost at sampling
levels of 10% or lower and are underestimated at 20%,
which suggests that for most experiments a sampling
level of below 25% is not recommended.
In summary, for 2D-HSQC NMR spectra, an NUS
schedule that acquires 25% of the 8,192 complex data
points of the 13C dimension gives the best solution
allowing rapid collection of data without the loss of
spectral integrity.
FIGURE 3 The effect of the number of transients on the signals acquired using E/A and States-TPPI pulse sequences. 13C slices from
the 25% non-uniformly sampled 2D-1H,13C HSQC NMR spectra showing the alanine multiplets corresponding to C(2) (A,B) and C(3) (C,D).
The region from the same slice where no peaks are expected is used to illustrate noise levels. The traces for spectra acquired with 2, 4 and
8 transients are shown. The traces from the States-TPPI spectra are overlaid with same trace from the E/A spectrum collected with
2 transients (grey) in order to show the position of missing peaks
6 JEEVES ET AL.
5 | SAMPLING SCHEDULES
Sampling schedules can make a large difference to data
for protein samples where weighting the distribution of
the increments sampled based on the transverse relaxa-
tion time (T2) of the sample can have dramatic
effects.[35,36] With samples of small molecules, for
example, most polar metabolites, the T2 of these
FIGURE 4 The effect of varying the sampling level on the multiplet signal of C(5) of glucose. The 13C trace of the 2D-1H,13C HSQCNMR
spectra collected using sampling levels of 50% (A), 30% (B), 25% (C), 20% (D), 10% (E) and 5% (F) are show together with the corresponding
noise from a range where no signals are expected. Arrows indicate fine features of the multiplet that are lost with lower sampling levels
TABLE 1 Contributions of each component to the overall multiplets of lactate with different sampling levels as measured by simulation
of the multiplet
Lactate C(2) observed
Sampling 12C(1), 13C(2), 12C(3) 13C(1), 13C(2), 12C(3) 12C(1), 13C(2), 13C(3) 13C(1), 13C(2), 13C(3)
100% 2 3 3 92
50% 2 3 3 92
30% 2 3 3 92
25% 2 3 3 92
20% 2 2 2 94
10% 2 0 0 98
5% 2 0 0 98
Lactate C(3) observed








Note: 2D-1H,13C HSQC NMR spectra with NUS levels of 100%, 50%, 30%, 25%, 20%, 10% and 5% were acquired, and the contributions of each
component of the multiplet were calculated based on the comparison of the real data with simulations of the multiplet with varying compo-
nent contributions. Each component relates to a different isotope incorporation into the carbons of lactate. The line-shape simulations were
performed within the MetaboLab software[20] using the pyGamma library.[9] C(1) of lactate is not observable by 2D-1H,13C HSQC NMR spec-
troscopy as it has no attached proton. No information on the isotopic state of C(1) can be assessed from observation of C(3) as the two bond
13C–13C J-coupling is too small to be resolved.
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molecules is quite long, and as such, varying the sam-
pling schedule should not influence the resulting spec-
trum as much.[37] Indeed, we did not find any
noticeable difference between NMR spectra acquired
using either sampling schedules weighted towards the
initial increments (Figure 5A,B) versus non-weighted
(Figure 5C) or a sampling schedule weighted towards
the beginning and the end of the indirect evolution
period (Figure 5D). As there is no effect of using differ-
ent sampling schedules, we do not recommend any
particular sampling scheme; they should all lead to
equivalent results. All sampling schedules, except those
used to produce the data for Figure 5, were weighted
towards the initial increments.
6 | SUITABILITY FOR HIGH-
THROUGHPUT MFA STUDIES
Observation of metabolism in real time is becoming
increasingly popular.[38–43] Usually, 1D NMR pulse
sequences or hyperpolarized samples are used to
acquire metabolic data from living samples. Although
hyperpolarisation is a truly fascinating technique, it
requires highly specialised equipment, beyond the capa-
bilities of most labs. Proton-detected 1D NMR pulse
sequences can provide metabolic tracing information on
a rapid timescale, however quantitative data can
only be obtained for sparse NMR spectra as spectral
congestion results in peak overlap.[14,15,42,43] We
FIGURE 5 The effect of weighting the sampling of 25% non-uniformly sampled 2D-1H,13C HSQC NMR spectra. Two front-end
weighted sampling schedules starting from different seeds were tested (A,B) with the 13C slice of the 2D-HSQC NMR spectrum
corresponding to C(5) of glucose is shown together with a corresponding noise region where no signals are expected (E,F). Non-weighted
(C,G) and front and back-end weighted (D,H) 25% non-uniformly sampled 2D-HSQC NMR spectra were also acquired
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therefore explored the possibility of acquiring 2D-HSQC
NMR spectra at rates suitable for high-throughput data
acquisition.
Using small NUS levels (5% or 10%), in combina-
tion with the enhancement of apparent signal
splittings,[15,22] it is possible to acquire 2D-HSQC NMR
spectra with enough spectral resolution in the 13C
dimension to resolve 13C–13C J-coupling-based signal
splitting in under 15 min (Figure 6). This is only possi-
ble for a limited number of metabolites with large and
well-resolved signals, such as lactate, due the limita-
tions of the observable dynamic range. This means that
the large signals are reconstructed successfully, but the
lack of data points results in poor reconstruction of
smaller signals, often resulting in them being absent in
the reconstructed spectrum. Increasing the J-coupling
splitting enhancement to eight resulted in the loss of
some features as seen by the disappearance of central
peak of the multiplet (Figure 6D). As there is little else
to differentiate between a spectrum collected with an
enhancement of 4% and 5% sampling level and a spec-
trum collected with an enhancement of 8% and 10%
sampling level (Table 2), and as both spectra take the
same amount of time to acquire, it is better to limit
the enhancement of the splitting due to J-coupling to
4% and instead reduce the sampling level to 5% in
order to retain all features of the multiplets. Rapid
collection of NMR data suitable for MFA studies is
therefore possible, with appropriate attention to the
parameters used.
7 | SUMMARY
This article describes some of the considerations that
need to be taken into account before setting up a tracer-
based experiment using 2D-HSQC NMR spectroscopy.
The limitation of the low sensitivity of NMR spectroscopy
compared with MS is counteracted by the richness of the
data that can be obtained. There is a need to speed up
NMR data acquisition, while still acquiring high-quality
data of sufficient signal strength, in order to make NMR
a viable tool for MFA studies. NUS plays a vital role in
this, but it must be used with the correct parameters in
order to yield meaningful data.
The choice of pulse sequence is vital in the elimina-
tion of artefacts that compromise data analysis when
using NUS. Collecting data with very few repetitions is
most effectively achieved with the use of echo/anti-echo
for coherence selection, as only two transients are
required for artefact removal.
While striving for data acquisition in the shortest pos-
sible time, it is important not to reduce the number of
points sampled such that the quality of the data is com-
promised. Equally, there is no need to sample more
points than necessary, as this achieves little and wastes
time. The use of 25% sampling provides the ideal compro-
mise between rapid data acquisition and high-quality
data output. The weighting of the non-uniformly sampled
points has no impact on spectra for MFA due to the small
relaxation rates in small molecules. In the emerging field
of high-throughput metabolic analysis, it is possible, with
FIGURE 6 The utility of non-uniformly sampled high resolution 2D-HSQC NMR spectra to high-throughput NMR studies. 13C-traces
of 5% non-uniformly sampled 2D-1H,13C HSQC NMR spectra collected with J-coupling splitting enhancement of 1 (A), 2 (B), 4 (C) and
8 (D) together with a corresponding noise region
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a very low NUS level, to acquire data rapidly enough to
make NMR spectroscopy a viable tool in this field.
This article focuses on multiplet analysis, but it is
worth noting that full isotopomer analysis requires the use
of MS data for accurate results.[7] MS can monitor all iso-
topomers, unlike NMR data, which may lack certain iso-
topomer information. For example, with a standard
2D-1H,13C HSQC approach, quaternary carbons do not
yield an NMR signal. In addition, NMR is blind to 12C;
therefore, it is not possible to directly quantify the amount
of 13C relative to 12C at any specific position using a single
sample. The combination of NMR multiplet data with MS
isotopomer data resolves this problem.[7]
In summary, NUS is essential for the rapid acquisi-
tion of 2D-HSQC NMR spectra, allowing NMR spectros-
copy to be a viable method for studying metabolism. The
implementation of NUS, together with the low transient
requirements of E/A and other methods such as enhance-
ment of splitting due to J-coupling,[15,22] allows the
acquisition of NMR data in a timely fashion.
8 | STANDARD PROCEDURE
Cells are cultured in the presence of isotopically labelled
tracer, with the choice of tracer dependent on what par-
ticular pathways are of interest. In the absence of a priori
knowledge, a metabolomics study can give insights into
which pathways may be of interest to a particular system.
Metabolites are extracted using a biphasic system to
separate polar molecules from lipids and remove other
interfering molecules such as proteins.[44] The sample is
split into portions for NMR (90%) and GC-MS (10%).
GC-MS is used to generate data giving number of
incorporated heavy atoms in each metabolite, known as
mass isotopomer distributions.[45,46] These data are not
adequately provided by NMR alone as such a strategy
would require the use of two samples in order to deter-
mine absolute fractional 13C enrichment and thus lead to
errors due to difficulties in reproducibility.
Two-dimensional HSQC NMR spectra are collected,
and multiplet analysis is performed to determine position
specific isotope incorporation, which cannot be achieved
by MS. The standard set-up for the NMR spectroscopy
suggested here involves collection of 2D-HSQC NMR
spectra with the use of E/A for coherence selection in
order to minimise artefacts. Full information on the
experimental set-up used in this study is given in the
methods section. At higher magnetic field stregnths, it
will become necessary to enhance the splitting due to
J-coupling in order to completely resolve the multi-
plet.[15,22] A Bruker pulse sequence capable of scaling the
appearance of J-coupling-based signal splitting can be
found in the data repository associated with this publica-
tion (http://doi.org/10.17605/OSF.IO/QTMGE).
The isotopologue data from GC-MS and the atom-
specific incorporation data from NMR spectroscopy are
combined for full isotopomer analysis.[7]
9 | METHODS
All 2D-HSQC NMR spectra were acquired using a Bruker
NEO 800-MHz NMR spectrometer equipped with a
1.7-mm z-PFG TCI CryoProbe. The 2D-HSQC NMR spec-
tra with echo/anti-echo gradient coherence selection
were acquired using our previously described pulse
sequence.[15,22] A presaturation pulse is used to suppress
the water resonance during the 1.5-s interscan relaxation
delay. The 1H dimension in all experiments was acquired
with a spectral width of 15.6 ppm using 512 complex data
points. In the fully sampled spectra (Figure 2), the 13C
dimension was acquired with a spectral width of
189.8 ppm using 8,192 complex data points resulting in
an experiment time of approximately 16 h. In spectra col-
lected using NUS without splitting enhancement
(Figures 3 and 5, Table 1), 25% of 8,192 complex data
points were collected in the 13C dimension resulting in
an experiment time of approximately 4 h. In spectra to
test the effect of NUS sampling level without the use of
signal splitting enhancement (Figure 4), either 5%, 10%,
20%, 25% or 50% of 8,192 complex data points were col-
lected in the 13C dimension resulting in experiment times
of approximately 0.8, 1.6, 3.2, 4 and 8 h, respectively. For
experiments acquired using scaling of the signal splittings
due to J-coupling in addition to NUS (Figure 6, Table 2),
the following set-up was used: Experiments with no scal-
ing were collected using either 5% or 10% of 8,192 com-
plex data points, experiments using twofold scaling were
collected using either 5% or 10% of 4,096 complex data
points, experiments using fourfold scaling were collected
using either 5% or 10% of 2,048 complex data points and
experiments using eightfold scaling were collected using
either 5% or 10% of 1,024 complex data points in the 13C
dimension[15,22] resulting in experiment times of 52, 104,
26, 52, 13, 26, 6.5 and 13 min, respectively. Fully sampled
spectra were processed using NMRPipe.[31] The non-
uniformly sampled spectra were reconstructed using the
IRLS algorithm with 20 iterations within MDDNMR[30,32]
(version 2.5) and processed using NMRPipe[31] (version
9.2). All spectra were processed with polynomial baseline
correction after manual phase correction.
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datasets are as follows: pulseSequences_fullSampling.
zip contains the fully sampled NMR spectra with E/A
(subdirectory 1), States-TPPI (subdirectory 2) and E/A
with sensitivity enhancement (subdirectory 3). The file
transients_sampling25.zip contains spectra with 25%
NUS with 2, 4 and 8 transients, respectively.
Subdirectories 1–3 contain E/A 2D-HSQC NMR spec-
tra, and subdirectories 4–6 contain States-TPPI 2D-
HSQC NMR spectra. samplingRates_transients2.zip
contains spectra exploring how much sampling is
needed using an E/A 2D-HSQC NMR pulse sequence.
Subdirectories 1–6 contain NMR spectra with sampling
rates of 50%, 30%, 25%, 20%, 10% and 5%, respectively.
The file samplingSchedules_sampling25_transients2.zip
contains NMR spectra with different sampling sched-
ules, and the file realTimeCapabilities.zip contains
NMR spectra to explore the possibility of real-time
acquisition of 2D-HSQC NMR spectra with sufficient
resolution to be able to observe 13C–13C J-couplings.
Please see the file metainformation.txt in the repository
for details. The file pulseSequence.zip contains an E/A
2D-HSQC NMR pulse sequence with the possibility to
scale the appearance of 13C–13C J-coupling constants
in the indirect dimension. The MetaboLab software
package is available at https://www.ludwiglab.org/
software-development.
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TABLE 2 The effect of increasing the enhancement of the splitting due to J-coupling on the contributions of each component to the














1 5% 2 0 0 98
2 5% 3 0 0 97
4 5% 2 0 0 98
8 5% 1 0 0 99
1 10% 2 0 0 98
2 10% 1 0 0 99
4 10% 2 0 0 98




NUS sampling level 12C(2), 13C(3) 13C(2), 12C(3)
1 5% 2 98
2 5% 2 98
4 5% 2 98
8 5% 0 100
1 10% 2 98
2 10% 1 99
4 10% 2 98
8 10% 1 99
Note: 2D-1H,13C HSQC NMR spectra with NUS levels of 5% and 10% were collected with either 1-, 2-, 4- or 8-times enhancement of splitting
due to J-coupling implemented. The contributions of each component to the multiplet were calculated by comparing the simulated multiplet
with the real data. The line-shape simulations were performed within the MetaboLab software[8] using the pyGamma library.[9] C(1) of
lactate is not observable by 2D-1H,13C HSQC NMR spectroscopy as it has no attached proton. No details of the status of C(1) lactate can be
determined by the observation of C(3) as the splitting due to J-coupling is too small to be resolved.
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